Interventions for ADHD in childhood and adolescence: A systematic umbrella review and meta-meta-analysis

Türk, Selina; Korfmacher, Ann-Kathrin; Gerger, Heike; Oord, Saskia Van der; Christiansen, Hanna

doi:10.1016/j.cpr.2023.102271

Cited by 3 publications

(2 citation statements)

References 81 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One moderate quality meta-analysis, one high quality meta-meta-analysis, and one high quality systematic review evaluated the efficacy of psychosocial interventions on ADHD, but all three considered these in combination with medication (Arnold et al, 2015 ; Türk et al, 2023 ; Van der Oord et al, 2008 ). All three studies showed that psychosocial interventions were moderately efficacious in reducing ADHD symptoms, but when combined with medication larger effect sizes were achieved.…”

Section: Resultsmentioning

confidence: 99%

Interventions for Young Children’s Mental Health: A Review of Reviews

Hudson,

Minihan,

Chen

et al. 2023

Clin Child Fam Psychol Rev

View full text Add to dashboard Cite

To determine the efficacy of intervention programs for young children (4–9 years) with emerging mental health needs, we conducted a review of meta-analytic and systematic reviews of the intervention literature. Of 41,061 abstracts identified and 15,076 screened, 152 review articles met the inclusion criteria. We reviewed interventions across multiple disciplines targeting: (1) general mental health concerns; (2) internalizing symptoms; (3) externalizing symptoms; (4) anxiety; (5) depression; (6) trauma; (7) symptoms of attention-deficit/hyperactivity disorder; and (8) mental health concerns associated with autism spectrum disorder. Substantial evidence was found for the efficacy of behavioral and cognitive behavioral interventions for general mental health concerns, externalizing symptoms (generally, as well as ADHD, conduct, and other behavioral symptoms) and internalizing symptoms (generally, as well as anxiety) aged 4–9 years. Emerging evidence was identified for interventions targeting trauma symptoms, depression symptoms, and social, emotional and behavioral symptoms in autism spectrum disorder in children aged 4–9 years. Currently there is only limited emerging evidence regarding non-behavioral or non-cognitive behavioral interventions for programs targeting children ages 4–9 years where the aim is to deliver an evidence-based program to improve child social, emotional and/or behavioral functioning. Given the recent rises in mental health needs reported in children, targeted behavioral-and/or cognitive behavior therapy-based interventions should be made widely available to children (and their families) who experience elevated symptoms.

show abstract

Section: Resultsmentioning

confidence: 99%

Interventions for Young Children’s Mental Health: A Review of Reviews

Hudson,

Minihan,

Chen

et al. 2023

Clin Child Fam Psychol Rev

View full text Add to dashboard Cite

show abstract

“…Psychopharmacology, although considered an efficient treatment with large effect sizes in short term trials ( Mechler et al, 2022 ) as long it is taken, has remarkable adverse effects (e.g., weight loss, sleep disturbance, irritability, tachycardia, headache), and dose increases along treatment are necessary to maintain the full efficacy of the drugs ( Caye et al, 2019 ). In this regard, an approach combining non-pharmacological and pharmacological treatments is recommended since it is considered efficacious at lower medication doses ( Caye et al, 2019 ; Wolraich et al, 2019 ; Drechsler et al, 2020 ) and Türk et al (2023) find that there is a lack of research on combined treatments.…”

Section: Introductionmentioning

confidence: 99%

Combining mindfulness and cognitive training in children with attention deficit hyperactivity disorder: study protocol of a pilot randomized controlled trial (the NeuroMind study)

Badia-Aguarón,

Royuela-Colomer,

Pera-Guardiola

et al. 2024

Front. Psychol.

View full text Add to dashboard Cite

IntroductionAttention Deficit Hyperactivity Disorder (ADHD) has a global mean prevalence of 5%. Cognitive Training (CT) and Mindfulness-Based Interventions (MBIs) have shown promising results in managing ADHD symptoms, but they are not its Treatment-As-Usual (TAU). The NeuroMind Study aims to evaluate the preliminary effectiveness and feasibility of three interventions: Mindfulness for Health (M4H), CT using the NeuronUP® platform (CT), and a combination of both, Mindfulness Cognitive Training (MCT). There is empirical evidence supporting the effectiveness of the M4H and NeuronUP® platform; however, this study explores for the first time the effectiveness of MCT and CT, as well as the integration of M4H into TAU. The objectives of this 5-month Randomized Controlled Trial (RCT) are: (1) To analyze the preliminary effectiveness and feasibility of M4H, CT or a combination of both (MCT) added to TAU for children with ADHD; (2) To evaluate the role of psychological process variables (mindfulness and emotional regulation) as mediators of 5-month follow-up clinical outcomes; (3) To preliminarily explore whether specific sociodemographic and clinical characteristics can predict the short-and medium-term clinical response to the specific treatments.Methods and analysisParticipants will be 120 children (7 to 12 years) with ADHD recruited at Child and Adolescent Mental Health Service (CAMHS) Sant Joan de Déu Terres de Lleida (Spain) randomly allocated to one of the four study arms: TAU vs. TAU + CT vs. TAU + M4H vs. TAU + MCT. An assessment to collect ADHD symptoms, Executive Functions (EF), comorbid symptoms and global functioning will be conducted pre-intervention, post-intervention (2 months after baseline) and at the 5-month follow-up. Linear mixed models and mediational models will be computed.DiscussionIf the preliminary effectiveness and feasibility of the MCT are demonstrated, this study could be a preliminary basis to do a full RCT with a larger sample to definitively validate the intervention. The MCT could be applied in clinical practice if it is definitively validated.Clinical trial registration:ClinicalTrials.gov, identifier, NCT05937347. https://clinicaltrials.gov/study/NCT05937347?locStr=Spain&country=Spain&cond=ADHD&intr=Mindfulness&rank=1.

show abstract